Introducing RevIT™ AAV Enhancer
Designed to deliver a higher AAV titer for any:

TransIT-VirusGEN® GMP Transfection Reagent

Proven Transfection for Therapeutic Viral Vector Manufacturing

TransIT-VirusGEN® GMP Transfection Reagent provides industry-leading lentivirus and AAV titers and is ideal for the production of cell and gene therapies. TransIT-VirusGEN® GMP is produced according to Good Manufacturing Practices and features release testing and quality documentation designed to streamline the process of ancillary material qualification, ensuring seamless transitions from discovery through large-scale manufacturing.

Learn More


The TransMission: NEW Mirus Blog!

We are excited to continue supporting the growth of the labs, companies and institutions that rely on Mirus products with the establishment of our official Mirus Bio blog: The TransMission.


FEATURED CITATION: TransIT®-mRNA Used to Develop an RNA-based Vaccine Against SARS-CoV-2

Product Usage: TransIT-mRNA Transfection Kit was used to deliver transcribed virus-derived replicon RNA molecules (including vaccine candidate repRNA-COV2S and control repRNA-GFP) to BHK cells for in vitro repRNA vaccine candidate qualification.



It isn't Transfection without the TransIT!

The TransIT-X2® Dynamic Delivery System is a single transfection solution for plasmid DNA, siRNA, CRISPR gRNA, Cas9 RNP.

Sample Now >>

What customers are saying about Mirus Bio

Next Testimonial